Isolation and Characterization of Poeciguamerin, a Peptide with Dual Analgesic and Anti-Thrombotic Activity from the IPoecilobdella manillensis/I Leech

• Published in: International journal of molecular sciences Vol. 24; no. 13
• Main Authors: Wang, Chaoming, Chen, Mengrou, Lu, Xiaoyu, Yang, Shuo, Yang, Min, Fang, Yaqun, Lai, Ren, Duan, Zilei
• Format: Journal Article
• Language: English
• Published: MDPI AG 01.07.2023
• Subjects: Peptides; China
• ISSN: 1422-0067
• DOI: 10.3390/ijms241311097

When Poecilobdella manillensis attacks its prey, the prey bleeds profusely but feels little pain. We and other research teams have identified several anticoagulant molecules in the saliva of P. manillensis, but the substance that produces the paralyzing effect in P. manillensis is not known. In this study, we successfully isolated, purified, and identified a serine protease inhibitor containing an antistasin-like domain from the salivary secretions of P. manillensis. This peptide (named poeciguamerin) significantly inhibited elastase activity and slightly inhibited FXIIa and kallikrein activity, but had no effect on FXa, trypsin, or thrombin activity. Furthermore, poeciguamerin exhibited analgesic activity in the foot-licking and tail-withdrawal mouse models and anticoagulant activity in the FeCl[sub.3]-induced carotid artery thrombosis mouse model. In this study, poeciguamerin was found to be a promising elastase inhibitor with potent analgesic and antithrombotic activity for the inhibition of pain and thrombosis after surgery or in inflammatory conditions.